Guillain-Barre Syndrome Therapeutics

Guillain-Barre Syndrome Therapeutics

Global Guillain-Barre Syndrome Therapeutics Market to Reach $850.7 Million by 2030
In the changed post COVID-19 business landscape, the global market for Guillain-Barre Syndrome Therapeutics estimated at US$589.1 Million in the year 2022, is projected to reach a revised size of US$850.7 Million by 2030, growing at aCAGR of 4.7% over the period 2022-2030. Intravenous Immunoglobulin, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$490.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Plasma Exchange segment is readjusted to a revised 4.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $174 Million, While China is Forecast to Grow at 4.3% CAGR
The Guillain-Barre Syndrome Therapeutics market in the U.S. is estimated at US$174 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$148.5 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.Select Competitors (Total 13 Featured) - Akari Therapeutics PlcBiotest AGChina Biologic Products Holdings, Inc.CSL Behring LLCGrifols SAKedrion SpANihon Pharmaceutical Co., Ltd.Octapharma AGShire PLCPlease note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.